These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [The progress on allergen-specific immunotherapy for bronchial asthma]. Liu HY; Xie LY; Zhou LF Zhonghua Jie He He Hu Xi Za Zhi; 2013 Jun; 36(6):450-4. PubMed ID: 24103210 [No Abstract] [Full Text] [Related]
6. [Immunotherapy with an oral Alternaria extract in childhood asthma. Clinical safety and efficacy and effects on in vivo and in vitro parameters]. Criado Molina A; Guerra Pasadas F; Daza Muñoz JC; Moreno Aguilar C; Almeda Llamas E; Muñoz Gomariz E; Font Ugalde P; Alonso Díaz C; Germán Cárdenas M; Sánchez Guijo P Allergol Immunopathol (Madr); 2002; 30(6):319-30. PubMed ID: 12464165 [TBL] [Abstract][Full Text] [Related]
7. Clinical and immunologic changes after allergen immunotherapy with Hop Japanese pollen. Park HS; Nahm DH; Kim HY; Suh YJ; Cho JW; Kim SS; Lee SK; Jung KS Ann Allergy Asthma Immunol; 2001 Apr; 86(4):444-8. PubMed ID: 11345290 [TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of high-doses sublingual immunotherapy in ultra-rush scheme in children allergic to grass pollen. Stelmach I; Kaczmarek-Woźniak J; Majak P; Olszowiec-Chlebna M; Jerzynska J Clin Exp Allergy; 2009 Mar; 39(3):401-8. PubMed ID: 19134016 [TBL] [Abstract][Full Text] [Related]
10. Immunoglobulin E and G antibody profiles to grass pollen allergens during a short course of sublingual immunotherapy. Aberer W; Hawranek T; Reider N; Schuster C; Sturm G; Kränke B J Investig Allergol Clin Immunol; 2007; 17(3):131-6. PubMed ID: 17583098 [TBL] [Abstract][Full Text] [Related]
11. Specific immunotherapy in asthma. Bousquet J; Michel FB Allergy Proc; 1994; 15(6):329-33. PubMed ID: 7721083 [TBL] [Abstract][Full Text] [Related]
12. Immunotherapy with a depigmented, polymerized vaccine of Olea europaea pollen allergens. Significantly reduces specific bronchial and skin test reactivity in sensitized patients after one year of treatment. Guerra F; Daza JC; Almeda E J Investig Allergol Clin Immunol; 2003; 13(2):108-17. PubMed ID: 12968395 [TBL] [Abstract][Full Text] [Related]
13. The effects of grass pollen allergoid immunotherapy on clinical and immunological parameters in children with allergic rhinitis. Keskin O; Tuncer A; Adalioglu G; Sekerel BE; Saçkesen C; Kalayci O Pediatr Allergy Immunol; 2006 Sep; 17(6):396-407. PubMed ID: 16925684 [TBL] [Abstract][Full Text] [Related]
18. [Evaluation of the pediatric aspects of the WHO document and meta-analysis of immunotherapy]. Ibáñez Sendín MD Allergol Immunopathol (Madr); 2000; 28(3):82-9. PubMed ID: 10867375 [TBL] [Abstract][Full Text] [Related]
19. Double-blind, placebo-controlled Alternaria alternata immunotherapy: in vivo and in vitro parameters. Lizaso MT; Tabar AI; García BE; Gómez B; Algorta J; Asturias JA; Martínez A Pediatr Allergy Immunol; 2008 Feb; 19(1):76-81. PubMed ID: 17662037 [TBL] [Abstract][Full Text] [Related]
20. Short-term subcutaneous grass pollen immunotherapy under the umbrella of anti-IL-4: A randomized controlled trial. Chaker AM; Shamji MH; Dumitru FA; Calderon MA; Scadding GW; Makatsori M; Jones I; He QA; Subramanian KK; Arm JP; Durham SR; Schmidt-Weber CB J Allergy Clin Immunol; 2016 Feb; 137(2):452-461.e9. PubMed ID: 26531865 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]